Bruker Q2 revenue $797M, -0.4% YoY; non-GAAP EPS $0.32, -38.5%; lowers FY2025 guidance

BRUKER CORP

2025-Q2 EPS reported $0.16 revenue$1,598,800,000

Q2 revenue $797.4M, organic -7.0% YoY from weak US academic and biopharma demand.
GAAP EPS $0.05; non-GAAP EPS $0.32, down 38.5% vs Q2 2024 $0.52.
BSI segment revenue $733.2M (organic -7.2%); BEST segment $66.3M (organic -4.8%).
FY2025 guidance cut: revenue $3.43-3.50B (2-4% reported growth), non-GAAP EPS $1.95-2.05 vs FY2024 $2.41.
Announced expanded cost initiative targeting $100-120M annual savings in FY2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.